tiprankstipranks
Advertisement
Advertisement

PCJENAV Stock Latest News

JenaValve Technology Advances U.S. Trilogy TAVR Launch With Early Use and AATS 2026 Push
Private CompaniesJenaValve Technology Advances U.S. Trilogy TAVR Launch With Early Use and AATS 2026 Push
2d ago
JENAV
JenaValve Highlights FDA-Approved Trilogy System Ahead of AATS 2026
PremiumPrivate Companies
JenaValve Highlights FDA-Approved Trilogy System Ahead of AATS 2026
4d ago
JENAV
JenaValve Highlights FDA-Approved Trilogy System Ahead of AATS 2026
PremiumPrivate Companies
JenaValve Highlights FDA-Approved Trilogy System Ahead of AATS 2026
4d ago
JENAV
JenaValve Technology Showcases Early U.S. Adoption and FDA-Backed Trilogy TAVR Launch
PremiumPrivate Companies
JenaValve Technology Showcases Early U.S. Adoption and FDA-Backed Trilogy TAVR Launch
9d ago
JENAV
JenaValve’s Trilogy System Sees Initial Clinical Use at Scripps Health
PremiumPrivate Companies
JenaValve’s Trilogy System Sees Initial Clinical Use at Scripps Health
10d ago
JENAV
JenaValve Technology Gains Momentum With Trilogy TAVR Adoption at Scripps Health
PremiumPrivate CompaniesJenaValve Technology Gains Momentum With Trilogy TAVR Adoption at Scripps Health
10d ago
JENAV
JenaValve Emphasizes Trilogy Delivery System Features for TAVR Precision
Premium
Private Companies
JenaValve Emphasizes Trilogy Delivery System Features for TAVR Precision
12d ago
JENAV
JenaValve Showcases Trilogy Delivery System Features for TAVR Procedures
Premium
Private Companies
JenaValve Showcases Trilogy Delivery System Features for TAVR Procedures
12d ago
JENAV
JenaValve Gains FDA Approval for Trilogy System in High-Risk Aortic Regurgitation
PremiumPrivate Companies
JenaValve Gains FDA Approval for Trilogy System in High-Risk Aortic Regurgitation
17d ago
JENAV
FDA Clearance Positions JenaValve’s Trilogy System in Niche TAVR Segment
PremiumPrivate Companies
FDA Clearance Positions JenaValve’s Trilogy System in Niche TAVR Segment
17d ago
JENAV
JenaValve Highlights Aortic Regurgitation Focus at Heart Valve Society 2026
PremiumPrivate Companies
JenaValve Highlights Aortic Regurgitation Focus at Heart Valve Society 2026
18d ago
JENAV
JenaValve Highlights Aortic Regurgitation Focus at Heart Valve Society 2026
PremiumPrivate Companies
JenaValve Highlights Aortic Regurgitation Focus at Heart Valve Society 2026
18d ago
JENAV
Specialized TAVR Valve Targets Native Aortic Regurgitation Segment
PremiumPrivate CompaniesSpecialized TAVR Valve Targets Native Aortic Regurgitation Segment
21d ago
JENAV
JenaValve Highlights Early U.S. Commercial Use of Trilogy TAVR System
Premium
Private Companies
JenaValve Highlights Early U.S. Commercial Use of Trilogy TAVR System
24d ago
JENAV
JenaValve Highlights Early U.S. Commercial Use of Trilogy TAVR for Aortic Regurgitation
Premium
Private Companies
JenaValve Highlights Early U.S. Commercial Use of Trilogy TAVR for Aortic Regurgitation
24d ago
JENAV
JenaValve’s Trilogy TAVR System Begins U.S. Commercial Use for Aortic Regurgitation
PremiumPrivate Companies
JenaValve’s Trilogy TAVR System Begins U.S. Commercial Use for Aortic Regurgitation
25d ago
JENAV
JenaValve Marks Initial U.S. Commercial Use of Trilogy TAVR System for Aortic Regurgitation
PremiumPrivate Companies
JenaValve Marks Initial U.S. Commercial Use of Trilogy TAVR System for Aortic Regurgitation
25d ago
JENAV
Early U.S. Commercial Use of Trilogy System Signals Initial Uptake in Aortic Regurgitation Market
PremiumPrivate Companies
Early U.S. Commercial Use of Trilogy System Signals Initial Uptake in Aortic Regurgitation Market
26d ago
JENAV
Early U.S. Commercial Use of JenaValve Trilogy System Signals Initial Market Uptake
PremiumPrivate Companies
Early U.S. Commercial Use of JenaValve Trilogy System Signals Initial Market Uptake
26d ago
JENAV
JenaValve Marks U.S. Commercial Launch of Trilogy TAVR System
PremiumPrivate CompaniesJenaValve Marks U.S. Commercial Launch of Trilogy TAVR System
1M ago
JENAV
FDA-Cleared Trilogy System Puts JenaValve in Focus at Major Cardiology Meeting
Premium
Private Companies
FDA-Cleared Trilogy System Puts JenaValve in Focus at Major Cardiology Meeting
1M ago
JENAV
JenaValve Highlights FDA-Approved Trilogy System for Aortic Regurgitation at ACC26
Premium
Private Companies
JenaValve Highlights FDA-Approved Trilogy System for Aortic Regurgitation at ACC26
1M ago
JENAV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >